Incruse Ellipta 55 micrograms inhalation powder, pre-dispensed *

  • Company:

    GlaxoSmithKline (Ireland) Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/14/922/001-003 55 microgram(s) H01AC,H01AC03 Powder for Inhalation